| Literature DB >> 30442164 |
Yassar A Qureshi1, M Muntzer Mughal2, Sheraz R Markar3, Borzoueh Mohammadi2, Jeremy George4, Martin Hayward5, David Lawrence5.
Abstract
BACKGROUND: Acquired aerodigestive fistula (ADF) are rare, but associated with significant morbidity. Surgery affords the best prospect of cure. We present our experience of the surgical management of ADFs at a specialist unit, highlighting operative techniques, challenges and assess clinical outcomes following intervention. We also illustrate findings of a Hospital Episodes Statistics search for ADFs.Entities:
Keywords: Aerodigestive fistula; Oesophageal cancer; Oesophageal surgery; Tracheo-oesophageal fistula
Mesh:
Year: 2018 PMID: 30442164 PMCID: PMC6238307 DOI: 10.1186/s13019-018-0799-1
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1CT scan of Patient 1 demonstrating the aerodigestive fistula (arrows)
Preceding history and intervention, prior to the diagnosis of ADF
| Patient | Age at ADF Diagnosis (years) | Sex | Preceding Diagnosis | Preceding Intervention | Chemo-Radiotherapy | Preceding Treatment Related Complication | Previous Endotherapy |
|---|---|---|---|---|---|---|---|
| 1 | 60 | F | SSCa Proximal Oesophagus | Definitive chemo-radiotherapy | Chemo-radiotherapy | Radiotherapy related stricture | -×2 stents |
| 2 | 57 | M | TBb | Medical therapy | – | – | – |
| 3 | 59 | M | Adenocarcinoma Distal Oesophagus | Ivor-Lewis Oesophagectomy | Neo-adjuvant chemotherapy | Anastomotic leak | – |
| 4 | 73 | M | Unknown | – | – | – | – |
| 5 | 32 | F | TBb | Medical Therapy | – | – | – |
| 6 | 33 | M | Boerhaave’s Syndrome | Repair of leak | – | Re-leak; stricture | -× 1 stent |
| 7 | 55 | F | Oesophageal B Cell lymphoma | Chemotherapy | Chemotherapy | – | – |
| 8 | 29 | F | Unknown | – | – | – | – |
aSCC- Squamous Cell Carcinoma; b TB- Tuberculosis
Anatomical and Clinical Features of the ADFs
| Patient | Time to ADF Development (months) | Fistula Site | Fistula Size (mm) | Main Symptoms | Endotherapy to Treat ADF |
|---|---|---|---|---|---|
| 1 | 15 | Proximal trachea | 12 | Aspiration | ×3 stents |
| 2 | > 30 years | Oesophagus-right bronchus intermedius 30 cm | 12 | Recurrent chest infections | – |
| 3 | 21 | Gastric conduit-lung 25 cm | 16 | Recurrent chest infections | Endoclip |
| 4 | > 30 years | Proximal trachea 17 cm | 5 | Aspiration; Respiratory embarrassment | – |
| 5 | 144 | Distal oesophagus-lung 38 cm | 15 | Haemoptysis | – |
| 6 | 3 | Oesophagus-carina 24 cm | 15 | Recurrent chest infections | ×3 stents |
| 7 | 3 | Oesophagus- left main bronchus 26 cm | 5 | Recurrent chest infections | – |
| 8 | > 20 years | Proximal trachea 17 cm | 3 | Recurrent chest infections | – |
Fig. 2Residual ADF (arrow) following treatment for oesophageal lymphoma
Fig. 3ADF (arrow) in a proximal location, as seen by oesophagoscopy
Fig. 4A bronchoscopic image of the ADF (arrow) close to the carina
Surgical Intervention for the Correction of ADF, and Post-Operative Complications
| Patient | Operation | Incision | Phases | Reconstruction | Complications |
|---|---|---|---|---|---|
| 1 | Oesophageal Exclusion and fistula repair with strap muscle | Left collar | 2 phase | Retrosternal Gastric conduit | – |
| 2 | Fistula Repair with intercostal muscle | Right PLa thoracotomy | 1 phase | n/a | Respiratory infection |
| 3 | Fistula Repair with intercostal muscle | Right PLa thoracotomy | 1 phase | n/a | – |
| 4 | Fistula Repair with strap muscle | Bilateral collar | 1 phase | n/a | Respiratory failure |
| 5 | Right lower lobe resection and fistula repair | Right PLa mini-thoracotomy | 1 phase | n/a | – |
| 6 | Oesophageal Exclusion and fistula repair | Left collar | 2 phase | Retrosternal Colonic conduit | – |
| 7 | Oesophagectomy and fistula repair with intercostal muscle | Left collar | 1 phase | Retrosternal Gastric conduit | Anastomotic leak |
| 8 | Fistula Repair with strap muscle | Bilateral collar | 1 phase | n/a | – |
aPL- Postero-lateral
HES data search for ADFs between 2000 and 2012 (a denotes hospitals that perform ≥20 oesophageal cancer resections per year)
| HES data (2000–2012) |
| % |
|
|---|---|---|---|
| Age ≥ 70 years | 35 | 49.3 | |
| Sex | |||
| Female | 35 | 49.3 | |
| Male | 36 | 50.7 | |
| Treatment | 17 | 24 | |
| Surgery | 9 | 12.7 | |
| Stenting of oesophagus | 8 | 11.3 | |
| Unknown | 54 | 76 | |
| Presenting Clinical Feature | |||
| Pneumonia | 18 | 25.4 | |
| Pleural effusion | 22 | 31 | |
| Pulmonary embolus | 1 | 1.4 | |
| Ischaemic cardiac event | 1 | 1.4 | |
| Unknown | 29 | 40.8 | |
| All Hospitals | |||
| 30-day mortality | 23 | 32.4 | |
| 90-day mortality | 30 | 42.3 | |
| Specialist Centresa | 16 | 22.5 | |
| 30-day mortality | 4 | 25 | 0.473 |
| 90-day mortality | 5 | 31.3 | 0.311 |